View in EDS

Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)–targeting antibody-drug conjugate (ADC), in combination with pembrolizumab in patients with platinum-resistant ovarian cancer.

Saved in:
Bibliographic Details
Title: Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)–targeting antibody-drug conjugate (ADC), in combination with pembrolizumab in patients with platinum-resistant ovarian cancer.
Authors: Matulonis, Ursula A.1 (AUTHOR) ursula_matulonis@dfci.harvard.edu, Vergote, Ignace2 (AUTHOR), Moore, Kathleen N.3 (AUTHOR), Martin, Lainie P.4 (AUTHOR), Castro, Cesar M.5 (AUTHOR), Gilbert, Lucy6,7,8 (AUTHOR), Xia, Yu9 (AUTHOR), Method, Michael10 (AUTHOR), Stec, James10 (AUTHOR), Birrer, Michael J.11 (AUTHOR), O'Malley, David M.12 (AUTHOR)
Source: Gynecologic Oncology. Sep2025, Vol. 200, p96-104. 9p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 188153485
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)–targeting antibody-drug conjugate (ADC), in combination with pembrolizumab in patients with platinum-resistant ovarian cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Matulonis%2C+Ursula+A%2E%22">Matulonis, Ursula A.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> ursula_matulonis@dfci.harvard.edu</i><br /><searchLink fieldCode="AR" term="%22Vergote%2C+Ignace%22">Vergote, Ignace</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Moore%2C+Kathleen+N%2E%22">Moore, Kathleen N.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Martin%2C+Lainie+P%2E%22">Martin, Lainie P.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Castro%2C+Cesar+M%2E%22">Castro, Cesar M.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gilbert%2C+Lucy%22">Gilbert, Lucy</searchLink><relatesTo>6,7,8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xia%2C+Yu%22">Xia, Yu</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Method%2C+Michael%22">Method, Michael</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Stec%2C+James%22">Stec, James</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Birrer%2C+Michael+J%2E%22">Birrer, Michael J.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22O'Malley%2C+David+M%2E%22">O'Malley, David M.</searchLink><relatesTo>12</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Gynecologic+Oncology%22">Gynecologic Oncology</searchLink>. Sep2025, Vol. 200, p96-104. 9p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=188153485
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ygyno.2025.06.016
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 9
        StartPage: 96
    Titles:
      – TitleFull: Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)–targeting antibody-drug conjugate (ADC), in combination with pembrolizumab in patients with platinum-resistant ovarian cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Matulonis, Ursula A.
      – PersonEntity:
          Name:
            NameFull: Vergote, Ignace
      – PersonEntity:
          Name:
            NameFull: Moore, Kathleen N.
      – PersonEntity:
          Name:
            NameFull: Martin, Lainie P.
      – PersonEntity:
          Name:
            NameFull: Castro, Cesar M.
      – PersonEntity:
          Name:
            NameFull: Gilbert, Lucy
      – PersonEntity:
          Name:
            NameFull: Xia, Yu
      – PersonEntity:
          Name:
            NameFull: Method, Michael
      – PersonEntity:
          Name:
            NameFull: Stec, James
      – PersonEntity:
          Name:
            NameFull: Birrer, Michael J.
      – PersonEntity:
          Name:
            NameFull: O'Malley, David M.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: Sep2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 00908258
          Numbering:
            – Type: volume
              Value: 200
          Titles:
            – TitleFull: Gynecologic Oncology
              Type: main
ResultId 1